about
AVPdb: a database of experimentally validated antiviral peptides targeting medically important viruses.Identification of a novel epitope in the C terminus of hepatitis C virus-E2 protein that induces potent and cross-reactive neutralizing antibodies.CrisprGE: a central hub of CRISPR/Cas-based genome editing.AVP-IC50 Pred: Multiple machine learning techniques-based prediction of peptide antiviral activity in terms of half maximal inhibitory concentration (IC50).A natural small molecule inhibitor corilagin blocks HCV replication and modulates oxidative stress to reduce liver damage.Mycobacterium tuberculosis Rv0366c-Rv0367c encodes a non-canonical PezAT-like toxin-antitoxin pairBioinformatic and mutational studies of related toxin-antitoxin pairs in Mycobacterium tuberculosis predict and identify key functional residues
P50
Q38490669-06DEE897-043E-4F90-9E1D-776B925FC48CQ38715557-B4BBA276-42B9-479F-8431-B17F6C7414FCQ38859113-0D765958-CE61-45D5-A850-304CF3D96108Q40693694-8F404972-FD50-4ACE-940A-B53D5075BAC9Q46244426-15EEEC9B-9081-4284-948E-C365CB9E4BE2Q61800874-FC69F956-B9BE-4690-B79C-8434FC8331E2Q90281783-893E90BC-D574-4877-89E2-F02352684EDF
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Himani Tandon
@ast
Himani Tandon
@en
Himani Tandon
@es
Himani Tandon
@nl
type
label
Himani Tandon
@ast
Himani Tandon
@en
Himani Tandon
@es
Himani Tandon
@nl
prefLabel
Himani Tandon
@ast
Himani Tandon
@en
Himani Tandon
@es
Himani Tandon
@nl
P106
P31
P496
0000-0002-3469-8449